NEW YORK (360Dx) – Hologic, Bio-Rad Laboratories, and Roche were among the companies that received US Food and Drug Administration clearances in June for their in vitro diagnostic tests, according to the FDA website.

The FDA cleared Hologic's Aptima Combo 2 Assay, a nucleic acid test that employs target capture for the detection and differentiation of ribosomal RNA from Chlamydia trachomatis or Neisseria gonorrhoeae and is used with the firm's Panther System to diagnose chlamydial or gonococcal urogenital disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.